XCE Tirzepatide is a novel dual agonist of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This pharmaceutical grade peptide is presented as white lyophilized powder with 99% purity, specifically designed for research applications.
The compound features a molecular weight of 4813.527g/mol and demonstrates significant potential in metabolic research. As a dual receptor agonist, XCE Tirzepatide combines the effects of two important incretin hormones in a single molecule, making it particularly valuable for scientific investigations into glucose metabolism and weight management.
Research applications of XCE Tirzepatide include studies on: glucose-dependent insulin secretion, gastric emptying regulation, appetite control mechanisms, and potential metabolic benefits. The compound has shown promise in preclinical studies for its ability to influence multiple metabolic pathways simultaneously.
Our XCE Tirzepatide is produced under strict quality control standards to ensure batch-to-batch consistency. The lyophilized form provides excellent stability for research purposes when stored properly at -20°C.
Note: This product is intended for research use only. Not for human consumption or diagnostic use. Researchers should handle this material following appropriate laboratory safety protocols.